Wound Closure Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Users, By Region, By Competition, 2020-2030F

Market Overview

The Global Wound Closure Devices Market, valued at USD 12.88 Billion in 2024, is projected to experience a CAGR of 6.64% to reach USD 18.94 Billion by 2030. Wound closure devices encompass a diverse range of medical instruments and materials, including sutures, staplers, adhesives, and sealants, utilized to approximate tissue and facilitate healing following surgical incisions or traumatic injuries. The market's expansion is fundamentally driven by a growing global surgical volume, increasing prevalence of chronic diseases such as diabetes, which leads to complex and non-healing wounds, and a rising incidence of traumatic injuries from accidents. The aging global population, inherently more susceptible to conditions requiring surgical intervention and experiencing slower wound healing, further contributes to this demand.

According to the British Diabetic Association, in March 2024, over 5 million individuals in the United Kingdom were living with diabetes, a condition significantly contributing to chronic wound development and the subsequent need for wound closure solutions. Despite this robust demand, a significant challenge impeding market expansion is the high cost associated with advanced wound closure technologies. This elevated pricing can restrict widespread adoption, particularly in emerging economies and healthcare systems with constrained budgets.

Key Market Drivers

The escalating prevalence of chronic wounds represents a primary catalyst for the Global Wound Closure Devices Market. Conditions such as diabetes, venous insufficiency, and pressure ulcers contribute significantly to this burden, necessitating advanced solutions for effective tissue approximation and healing. These complex wounds often require specialized closure techniques to prevent infection and promote successful regeneration, driving demand for innovative sutures, sealants, and staplers. According to the International Diabetes Foundation as reported in "Chronic wounds: a rising public health concern", in April 2024, 40 to 60 million people globally are affected by diabetic foot ulcers, highlighting the extensive need for sophisticated wound management. Concurrently, the increasing volume of surgical procedures worldwide is a substantial driver. As healthcare access expands and medical advancements enable a wider range of interventions, the number of operations performed continues to grow. Every surgical incision requires precise closure to ensure optimal patient outcomes and reduce recovery times. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in June 2025, their annual Global Survey reported more than 17.4 million surgical procedures performed by plastic surgeons alone, indicating a significant and consistent demand across various surgical specialties for reliable wound closure devices.

This dual impetus from chronic wound management and surgical demand is further supported by continuous innovation within the industry. Companies are actively developing next-generation technologies to address unmet clinical needs, including biodegradable materials and antimicrobial properties. Such developments attract substantial financial backing. According to Medical Device Network, in May 2023, wound management company RedDress successfully raised $26 million in a Series D financing round to further advance its blood-based wound healing technology. This investment underscores the robust market confidence in novel solutions aimed at improving healing processes and patient quality of life.

Download Free Sample Report

Key Market Challenges

The high cost associated with advanced wound closure technologies represents a significant impediment to the growth of the Global Wound Closure Devices Market. Elevated pricing directly restricts widespread adoption, particularly within emerging economies and healthcare systems operating under constrained budgets. This financial barrier limits the ability of many providers to invest in newer, often more effective, solutions despite their potential clinical benefits.

Healthcare institutions frequently face difficult choices in allocating resources. For instance, according to the American Hospital Association, medical supply expenses constituted approximately 10.5% of the average hospital’s budget, totaling $146.9 billion in 2023, an increase of $6.6 billion over 2022. This substantial and rising expenditure on supplies means that advanced wound closure devices, while offering improved patient outcomes, may be deprioritized in favor of more basic or essential supplies when budgets are tight. Consequently, market expansion slows as the adoption rate of these higher-priced innovations is curtailed, limiting their overall reach and impact within the global healthcare landscape.

Key Market Trends

The Global Wound Closure Devices Market is experiencing a significant transformation driven by the shift towards minimally invasive and non-invasive closure techniques. This trend is fueled by increasing patient demand for reduced post-operative pain, faster recovery times, and improved cosmetic results, leading to a growing preference for procedures requiring smaller incisions. Consequently, there is an escalated need for specialized wound closure devices compatible with these advanced surgical approaches, including high-precision tissue adhesives, sealants, and redesigned stapling systems. According to the American Hospital Association, as of 2024, the da Vinci robotic surgical system facilitated approximately 2.68 million procedures globally, showcasing the widespread adoption of advanced minimally invasive methods. Further supporting this momentum, Johnson & Johnson Services, Inc. launched the ECHELON LINEAR Cutter in the U. S. market in May 2024, which features 3D-Stapling technology to enhance staple line security and reduce surgical risks in complex procedures.

Concurrently, the expansion of wound closure products into outpatient and home care settings represents another pivotal trend influencing the market. This shift is primarily driven by healthcare systems aiming to reduce costs, enhance patient convenience, and manage a growing aging population outside traditional inpatient facilities. The increased emphasis on decentralized care propels the demand for wound closure solutions that are user-friendly, cost-effective, and suitable for application by non-specialist caregivers or patients themselves. According to Statistics Canada, in 2023, the proportion of individuals aged 65 and older in the total population was 18.9%, indicating a demographic segment with a higher propensity for chronic wounds that often require ongoing home-based management. Reflecting this strategic direction, Cardinal Health, in June 2023, announced plans for a new distribution center in South Carolina, explicitly designed to bolster its At-Home Solutions business, a key provider of home healthcare medical supplies across the United States. This development highlights the industry's focus on supporting effective wound management within these expanding care environments.

Segmental Insights

The sutures segment is experiencing rapid growth within the Global Wound Closure Devices Market, primarily driven by a worldwide increase in surgical procedures. This surge is attributed to an aging global population and the rising incidence of chronic conditions requiring surgical intervention. Concurrently, significant technological advancements in suture design, including absorbable, antimicrobial-coated, and barbed sutures, are enhancing wound healing, minimizing infection risks, and improving overall patient outcomes. These innovations, often subject to rigorous evaluation by regulatory bodies such as the Food and Drug Administration, provide surgeons with more effective and specialized tools for diverse surgical applications, further solidifying the segment's expansion.

Regional Insights

North America leads the global wound closure devices market, primarily driven by its well-established healthcare infrastructure and substantial healthcare expenditure, which facilitate the adoption of advanced medical technologies. The region benefits from a high volume of surgical procedures, propelled by an aging population and the increasing prevalence of chronic conditions, thereby escalating the demand for effective wound management solutions. Furthermore, a robust regulatory environment, exemplified by the U. S. Food and Drug Administration (FDA) approvals, encourages continuous technological advancements and rapid product launches by key market players. This combination of factors ensures a consistent push towards innovative and efficient wound closure devices within the region.

Recent Developments

• In May 2025, Summit Products Group announced a strategic alliance with NovaBone Products, a prominent developer of regenerative medicine biomaterials. As part of this collaboration, Summit Products Group became the exclusive distributor for NovaForm® Wound Matrix. This proprietary wound dressing, formulated with bioglass and collagen, had recently received 510(k) clearance from the FDA. The partnership aims to enhance clinician access to advanced regenerative wound care technologies, directly impacting the market for wound closure devices by providing innovative solutions that support precision and regeneration in surgical and procedural settings.

• In April 2025, Henry Schein, Inc. entered into a new distribution agreement with Health Future, a consortium comprising Oregon hospitals and health systems. This collaboration granted Health Future access to Henry Schein’s disposable skin stapler and skin staple remover. These essential wound closure products were subsequently integrated into various wound closure procedures across Health Future’s 22 hospitals, clinics, and care centers. The partnership aimed to streamline procurement processes, enhance resource efficiency within the healthcare organizations, and ultimately improve patient outcomes through reliable wound closure solutions.

• In October 2024, Corza Medical introduced its new Onatec ophthalmic microsurgical sutures during the American Academy of Ophthalmology (AAO) conference in Chicago. This new product launch addressed the need for enhanced precision in microsurgical procedures. The sutures feature high-tempered stainless-steel needles, specifically designed to increase resistance to bending and improve overall durability. This innovation in suture technology is expected to provide surgeons with more reliable tools for intricate ophthalmic wound closure, contributing to improved surgical efficiency and patient recovery in specialized fields.

• In September 2024, Tides Medical, a Los Angeles-based company, launched APLICOR 3D, an innovative personalized wound care interoperative 3D printer. This breakthrough research and new product introduction leverages artificial intelligence and 3D printing technology to create customized skin grafts using a patient's own tissue. This advanced device aims to revolutionize the repair of damaged skin, offering tailored solutions for complex wound closure. The introduction of such advanced technology is anticipated to significantly contribute to advancements in personalized wound management and healing processes.

Key Market Players

• Merck KgaA
• 3M Company
• Johnson & Johnson
• B. Braun SE
• Medtronic Plc
• Baxter International Inc
• Integra LifeSciences Corporation
• Smith & Nephew plc
• Stryker Corporation
• Chemence Medical, Inc

Report Scope:

In this report, the Global Wound Closure Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Wound Closure Devices Market, By Product:

o   Strips

o   Adhesives

o   Staples

o   Sutures

o   Sealants

• Wound Closure Devices Market, By End User:

o   Hospitals & clinics

o   Ambulatory Surgical Services

o   Others

• Wound Closure Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Wound Closure Devices Market.

Available Customizations:

Global Wound Closure Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Wound Closure Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]